RNTX insider transaction filings
Rein Therapeutics, Inc. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-05-28. Screen RNTX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-28 | 4 | VON RICKENBACH JOSEF H — Director | Purchase (P): 3,420 @ $1.04 · Purchase (P): 15,950 @ $1.05 · Purchase (P): 23,190 @ $1.06 · Purchase (P): 4,500 @ $1.07 | EDGAR |
| 2026-05-13 | 4 | WINDSOR JAMES BRIAN — See Remarks, Director | Purchase (P): 25,000 @ $1 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Voss Capital, LP — 10% owner Voss Value Master Fund, LP — 10% owner Voss Value-Oriented Special Situations Fund, LP — 10% owner Voss Advisors GP, LLC — 10% owner Cocke Travis W. — 10% owner | Purchase (P): 104,183 @ $1.22 | EDGAR |
| 2025-10-28 | 4 | Voss Capital, LP — 10% owner Voss Value Master Fund, LP — 10% owner Voss Value-Oriented Special Situations Fund, LP — 10% owner Voss Advisors GP, LLC — 10% owner Cocke Travis W. — 10% owner | Purchase (P): 30,176 @ $1.39 · Purchase (P): 92,642 @ $1.37 · Purchase (P): 4,840 @ $1.37 · Purchase (P): 178,392 @ $1.39 | EDGAR |
| 2025-07-23 | 4 | Aivado Manuel — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | Fairey William — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | Ambros Reinhard J. — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | Musso Alan A — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2025-07-23 | 4 | VON RICKENBACH JOSEF H — Director | Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Rein Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-21 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-01-16 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-11 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2025-11-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-22 | 8-K | 8.01 — Other Events | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RNTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →